Related Experiment Video
Updated: May 28, 2026

Coupled Assays for Monitoring Protein Refolding in Saccharomyces cerevisiae
Published on: July 9, 2013
A fluorescence-based microtiter plate assay for γ-glutamylcyclotransferase
Philip G Board1, Inca Hutchinson
1John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia. philip.board@anu.edu.au
A new fluorescence assay quantifies gamma-glutamylcyclotransferase (GGCT) activity. This method enables high-throughput screening for GGCT inhibitors, valuable for treating genetic disorders and cancer research.
Area of Science:
- Biochemistry
- Enzymology
- Assay Development
Background:
- Gamma-glutamylcyclotransferase (GGCT) is crucial in the gamma-glutamyl cycle.
- GGCT activity leads to 5-oxoproline accumulation in glutathione synthetase deficiency.
- GGCT is implicated as a potential biomarker in various cancers.
Purpose of the Study:
- To develop a high-throughput screening assay for GGCT inhibitors.
- To facilitate the study of GGCT's role in disease and cancer.
Main Methods:
- A fluorescence-based 96-well plate assay was developed.
- Assay measures the rate of gamma-glutamylcysteine cleavage by GGCT.
- Residual substrate is quantified via fluorometric detection after derivatization.
Main Results:
- The assay demonstrates sensitivity for detecting low-affinity competitive inhibitors.
- The method is simple and suitable for microtiter plate formats.
- The assay is effective for high-throughput screening of GGCT inhibitors.
Conclusions:
- A novel, sensitive, and high-throughput compatible assay for GGCT activity has been established.
- This assay will aid in discovering GGCT inhibitors for therapeutic applications and cancer research.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
08:43A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017